Overview

A Trial of Doxycycline in Renal Disease

Status:
Completed

Trial end date:
2018-01-01

Target enrollment:

Participant gender:

Summary

The goal of this trial is to evaluate whether subantimicrobial-dose of doxycycline (20mgBID) will affect serum and urine biomarkers of fibrosis in patients with pre-dialysis chronic kidney disease.

Phase:

Phase 1

Details

Lead Sponsor:

University of California, San Francisco

Treatments:

Doxycycline